Myocardial protection at a crossroads: the need for translation into clinical therapy. - Wikidata - wikimedia - TriplyDB

Myocardial protection at a crossroads: the need for translation into clinical therapy.

Myocardial protection at a crossroads: the need for translation into clinical therapy.

http://www.wikidata.org/entity/Q35844649

about

Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapies Cardioprotection during cardiac surgery Sex-based differences in cardiac ischaemic injury and protection: therapeutic implications Role of epoxyeicosatrienoic acids in protecting the myocardium following ischemia/reperfusion injury Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway.Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart Mitochondria selective S-nitrosation by mitochondria-targeted S-nitrosothiol protects against post-infarct heart failure in mouse hearts.Lack of cardioprotection from subcutaneously and preischemic administered liraglutide in a closed chest porcine ischemia reperfusion model Hypothermia and postconditioning after cardiopulmonary resuscitation reduce cardiac dysfunction by modulating inflammation, apoptosis and remodeling.Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects.Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I.Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.Reduction of early reperfusion injury with the mitochondria-targeting peptide bendavia Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function Mitochondrial KATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts.Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction 4'-Chlorodiazepam, a translocator protein (18 kDa) antagonist, improves cardiac functional recovery during postischemia reperfusion in rats.Adjuvant cardioprotection in cardiac surgery: update.Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner.Glutathionylation of the L-type Ca2+ channel in oxidative stress-induced pathology of the heart.Role of microRNAs in cardiac preconditioning The late phase of preconditioning and its natural clinical application--gene therapy Myocardial function improved by electromagnetic field induction of stress protein hsp70.Mediterranean diet and cardioprotection: the role of nitrite, polyunsaturated fatty acids, and polyphenols.The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs Reactive oxygen species in cardiovascular disease.Cardiac microvascular barrier function mediates the protection of Tongxinluo against myocardial ischemia/reperfusion injury.Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury.SIRT1-mediated acute cardioprotection.Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury

P2860

Q24234559-E9933A2E-44B2-40F9-90ED-4970EB3E835E Q24236243-C5DB248C-8D53-4C1C-8AE4-63FAF94ABF44 Q24289195-D3A9B421-8356-4825-8C71-CE629156E4CA Q26866366-CD38FA36-0BF4-4281-9EB7-0187ECA8760F Q26996309-2D6108DC-F5AD-46E0-A6FB-8884820476C6 Q28397180-EFC6D791-C191-4E88-AA1D-5C533DCBC463 Q28534767-6260BAD9-3DC7-4CD2-9327-C7BA34E9BCFF Q28568343-1F27E5FF-DB33-4B61-9FC1-46BCA6F92FF4 Q30457378-38CCC5AB-1D1D-4FCB-9AC2-E9D6C7CB3D7F Q30492315-55E87730-A9E2-4B45-9783-4A782211E68A Q30597699-DA2A9452-7545-414A-B1AC-92B3219884DF Q33486125-33EA7D5B-3267-4176-8722-E3BF2F5B3785 Q33512531-86CD50C1-A85C-4938-ADC2-71CECF19447E Q33565870-865CB26A-197F-4FC3-A11C-57E1F3568C3A Q33606173-75D7A572-3DD7-410D-987D-AB60B436F97B Q33606564-3D7514A9-34C1-4A4C-9290-46BE45BF903B Q33714350-FB7A4956-60A3-4040-AEC2-53B2A714232A Q33919143-DFDF3173-4253-4F3A-A975-327162CF136F Q33928468-B75CAEBE-3C73-4F24-B89B-A08D40AC298C Q33994857-AC5E6849-33B0-41F3-B879-0C20B808FA4A Q34042151-5EEB0544-C258-4A42-A720-05B94EFEFA50 Q34043095-30ABD5C0-DAFA-4C0B-BEF5-ED346184662C Q34062698-E5D08997-9FEA-4B09-8E68-5B2239CC8313 Q34111148-4FD11B3D-88EB-4F64-9296-15AAB58B4C50 Q34120490-F3F4C93F-9F35-47F6-AD20-6A20A75F6772 Q34216449-9965E455-56D5-40D8-BE34-B5050C9AA57E Q34247485-FA60D43A-9FC5-41AD-9C14-E5667CB19E26 Q34357844-B939DAC4-9476-47AD-A4D6-F2493CEB5A1D Q34487060-BF12710E-2FAA-49F0-B559-1DEF5CE75814 Q34503344-476C91EF-833C-4C68-AC50-C19488EFD806 Q34633367-55DC22C7-BAF8-49B1-9EAE-0415FBFC6EDA Q34786639-2CD07D5F-D7F9-41FC-8A23-0A27FAE3D53D Q35053534-85786398-AC05-4B90-A835-BDC978AA8399 Q35085312-5EBDD605-E796-434C-A85B-EAF881D8D8B4 Q35165194-70B61CF3-C5B1-41F3-8BFF-DF15C99FB6B2 Q35186568-75241D88-C559-4A28-9FAF-B4F19DA564B3 Q35219366-05A40010-FF9F-4D4E-B091-0F4E02443853 Q35225599-8CFD7141-2E22-4412-9947-ADED04D3709F Q35395805-37C37549-8561-41D7-A2A8-435DF8F3A6FF Q35424798-8F87E78A-663B-409E-971A-F7E5CF2D6FC0

P2860

Myocardial protection at a crossroads: the need for translation into clinical therapy.

http://www.wikidata.org/entity/Q35844649

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Myocardial protection at a crossroads: the need for translation into clinical therapy.

@ast

Myocardial protection at a crossroads: the need for translation into clinical therapy.

@en

type

label

Myocardial protection at a crossroads: the need for translation into clinical therapy.

@ast

Myocardial protection at a crossroads: the need for translation into clinical therapy.

@en

prefLabel

Myocardial protection at a crossroads: the need for translation into clinical therapy.

@ast

Myocardial protection at a crossroads: the need for translation into clinical therapy.

@en

P1433

Q35844649-86F698A5-9F2B-456D-8173-7721DF476E5B

P1476

Q35844649-B2A66A19-BA44-401E-9807-16FBBA89E932

P2093

Q35844649-08A8CEB2-2238-4C12-A6D2-910E6E21A63C

Q35844649-25CE7DAF-0AA5-4208-8D3E-A63492213C3E

Q35844649-5C73E5E1-FF55-4ACD-9127-E9A716069AE9

Q35844649-74DF3613-CDD7-4403-984D-EE0508F6FB64

Q35844649-8BFD1665-FCAD-42FD-B8CF-204998B525D3

Q35844649-A3A0DD72-E9AB-4E39-9C97-8A766FEF8941

Q35844649-CF4BFF75-5314-436F-9C17-E890205EE498

P304

Q35844649-E65076F2-E9F3-4843-BF61-8EF1CCA8BBA4

P31

Q35844649-4957F6FD-C782-4493-8BD3-E497D1B9EAD6

P356

Q35844649-0FB03776-763A-4E4D-8D66-3C27B75516F0

P433

Q35844649-5BAF3470-5747-481E-BECC-CBDC3742FA0C

P478

Q35844649-D4F5E1BE-9B7F-43AF-96A7-D01A8C99CDF1

P50

Q35844649-9D55DEFC-48E0-42B5-AF12-149104584510

P577

Q35844649-6051269B-BCCE-4884-9BC7-1E134CB7783D

P698

Q35844649-4987EDE2-CA5F-4E2E-B067-6A1A07047072

P356

01.RES.0000137171.97172.D7

P1433

Circulation Research

P1476

Myocardial protection at a crossroads: the need for translation into clinical therapy.

@en

P2093

David A Lathrop

http://www.w3.org/2001/XMLSchema#string

David Balshaw

http://www.w3.org/2001/XMLSchema#string

Garrett Gross

http://www.w3.org/2001/XMLSchema#string

Lance Becker

http://www.w3.org/2001/XMLSchema#string

NHLBI Working Group on the Tra ...... ecting the Heart from Ischemia

http://www.w3.org/2001/XMLSchema#string

Robert Mentzer

http://www.w3.org/2001/XMLSchema#string

Roberto Bolli

http://www.w3.org/2001/XMLSchema#string

P304

125-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.RES.0000137171.97172.D7

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15271864

http://www.w3.org/2001/XMLSchema#string